EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Hypothalamic obesity: Epidemiology in rare sellar/suprasellar tumors—A German claims database analysis

Julian Witte iD, Bastian Surmann iD, Manuel Batram iD, Markus Weinert iD, Mathias Flume, Nicolas Touchot iD, Julia Beckhaus iD, Carsten Friedrich, Hermann L Müller iD

Journal of Neuroendocrinology · 2024-12 · 36 (12)

DOI: 10.1111/jne.13439 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuroendocrinology, online erschienen am 27.08.2024. Verfasst von Julian Witte und 8 weiteren Autor:innen. Beteiligte Einrichtung: Vandage GmbH, Bielefeld, Germany. Hauptthemen laut MEDLINE: Databases, Factual, Obesity. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Rhythm Pharmaceuticals, Inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypothalamic obesity (HO) is defined as abnormal weight gain resulting in severe persistent obesity due to physical, tumor‐ and/or treatment‐related damage to the hypothalamus. HO epidemiology is poorly understood. We developed a database algorithm supporting the standardized identification of tumor/treatment‐related HO (TTR‐HO) patients. The algorithm is used to estimate incidence rates of TTR‐HO patients in the German healthcare context from a representative claims database ( n = 5.42 million) covering 2010–2020. Patients were identified based on surgery/radiotherapy procedures and HO‐associated tumor diagnoses ( n = 3976). HO was defined by incident obesity and validated based on incident diabetes insipidus diagnoses and desmopressin prescription within a 12‐month period after surgery/radiotherapy. Uncertainty due to algorithm definitions is explored in sensitivity analyses. Estimated annual incidence of TTR‐HO in Germany is between 0.7 and 1.7 cases per 1,000,000 persons (2019 prevalence: n = 1262 patients). With observed cases in all age groups, two HO‐incidence peaks are identified: children/young adults aged 10–24 years and adults aged 40–44 years. Most frequent HO‐validated tumor diagnoses are benign sellar/suprasellar tumors (6.1/1,000,000 persons over 9 years), including tumors of the craniopharyngeal duct (1.3/1,000,000), neoplasms of the pituitary gland (4.1/1,000,000), and nonspecific brain tumors of endocrine glands (2.4/1,000,000). This is the first real‐world database analysis of TTR‐HO epidemiology, refining current estimates of HO epidemiology and early patient identification. A more comprehensive characterization of patients with HO as well as a better understanding of clinical implications will be crucial in developing optimal treatment strategies to improve patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Databases, FactualObesityHumansGermanyAdultChildAdolescentFemaleMaleYoung AdultMiddle AgedIncidenceAgedHypothalamic DiseasesPituitary NeoplasmsChild, Preschool

Stichwörter der Autor:innen

craniopharyngiomaendocrinologyhypothalamic obesityrare sellar/suprasellar tumorstumor/treatment related HO

Autor:innen und Institutionen

  • Vandage GmbH, Bielefeld, Germany.
  • Gene Access GmbH, Dortmund, Germany.
  • Rhythm Pharmaceuticals, Inc., Boston, Massachusetts, USA.
  • Department of Pediatrics and Pediatric Hematology/Oncology, University Children's Hospital, Carl von Ossietzky University, Klinikum Oldenburg AöR, Oldenburg, Germany.

ORCID-Profile: Julian Witte, Bastian Surmann, Manuel Batram, Markus Weinert, Nicolas Touchot, Julia Beckhaus, Hermann L Müller

Förderung

  • Rhythm Pharmaceuticals, Inc.

Zitieren

APA

Witte, J., Surmann, B., Batram, M., Weinert, M., Flume, M., Touchot, N., Beckhaus, J., Friedrich, C., & Müller, H. L. (2024). Hypothalamic obesity: Epidemiology in rare sellar/suprasellar tumors—A German claims database analysis. Journal of Neuroendocrinology, 36(12). https://doi.org/10.1111/jne.13439

Vancouver

Witte J, Surmann B, Batram M, Weinert M, Flume M, Touchot N, et al. Hypothalamic obesity: Epidemiology in rare sellar/suprasellar tumors—A German claims database analysis. Journal of Neuroendocrinology. 2024;36(12). doi:10.1111/jne.13439

BibTeX
@article{Witte2024,
  author = {Witte, Julian and Surmann, Bastian and Batram, Manuel and Weinert, Markus and Flume, Mathias and Touchot, Nicolas and Beckhaus, Julia and Friedrich, Carsten and Müller, Hermann L},
  title = {Hypothalamic obesity: Epidemiology in rare sellar/suprasellar tumors—A German claims database analysis},
  journal = {Journal of Neuroendocrinology},
  year = {2024},
  volume = {36},
  number = {12},
  doi = {10.1111/jne.13439}
}
Kostenlos starten →